2m 2m 2m 2m 2m 2m 2m
CytomX Therapeut (CTMX)
NASDAQ
$3.29+$0.19 (+6.13%)
Price as of Aug 03, 2026 6:42 AM EDT- $674.9MMarket Cap
- 31.91%1-Year Change
- BiotechnologyIndustry
CytomX Therapeut (CTMX)
$3.29+$0.19 (+6.13%)
Earnings Score
Valuation | CTMX | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -1 | ||
Growth | -1 | ||
Low Earnings Volatility | 21 |
Momentum Score
Valuation | CTMX | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | -12.62% | ||
12-Month Momentum | 64.38% | ||
3-Month Risk Adjusted Momentum | -57.17% | ||
12-Month Risk Adjusted Momentum | 69.39% |
True Yield
Valuation | CTMX | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | 2.79% | ||
Net Debt Paydown Yield | N/A |
Financial Health Score
Valuation | CTMX | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 5 |